Company to begin shipping HIV-1 incidence test.

2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Calypte Biomedical Corporation (HIV) announced that it began shipping its HIV-1 BED Incidence EIA test (Incidence Test).

The first shipment is destined for South Africa, and the company currently has initial orders for approximately 12,000 tests worldwide. Shipments to China and Brazil should commence in the coming weeks.

In April 2004, the company announced that it had been granted a worldwide non-exclusive license by the United States Centers for Disease Control and Prevention (CDC) to commercially manufacture and sell a unique test that was developed by the CDC in order to help epidemiologists and researchers …